GUARDANT HEALTH INC (1GH.MI) Stock Price, Forecast & Analysis
Europe - BIT:1GH - US40131M1099 - Common Stock
1GH.MI Key Statistics, Chart & Performance
The current stock price of 1GH.MI is 46.02 EUR.
1GH.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRE.DE | FRESENIUS SE & CO KGAA | 17.64 | 27.62B | ||
| 1FME.MI | FRESENIUS MEDICAL CARE AG | 12 | 24.58B | ||
| FME.DE | FRESENIUS MEDICAL CARE AG | 12.73 | 24.06B | ||
| V3V.DE | FAMICORD AG | 37.86 | 93.49M | ||
| HI.MI | HEALTH ITALIA SPA | 17.71 | 54.53M | ||
| EUK.MI | EUKEDOS SPA | N/A | 17.05M |
Related stock screener links
About 1GH.MI
Company Profile
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 1,999 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
Company Info
GUARDANT HEALTH INC
3100 Hanover Street
Palo Alto CALIFORNIA US
Employees: 1999
Phone: 18556988887
GUARDANT HEALTH INC / 1GH.MI FAQ
What does 1GH do?
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 1,999 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
What is the current price of 1GH stock?
The current stock price of 1GH.MI is 46.02 EUR.
Does 1GH stock pay dividends?
1GH.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1GH stock?
1GH.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How many employees does GUARDANT HEALTH INC have?
GUARDANT HEALTH INC (1GH.MI) currently has 1999 employees.
What is GUARDANT HEALTH INC worth?
GUARDANT HEALTH INC (1GH.MI) has a market capitalization of 5.74B EUR. This makes 1GH.MI a Mid Cap stock.
1GH.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1GH.MI.
1GH.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1GH.MI. 1GH.MI may be in some trouble as it scores bad on both profitability and health.
1GH.MI Financial Highlights
Over the last trailing twelve months 1GH.MI reported a non-GAAP Earnings per Share(EPS) of -2.91. The EPS decreased by -1.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.07% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
1GH.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of 10.91% and a revenue growth 26.23% for 1GH.MI